Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Apolipoprotein E in progressive supranuclear palsy in Japan


Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease which shows several psychiatric and neurologic symptoms: pseudobulbar palsy, supranuclear ocular palsy, extrapyramidal rigidity, gait ataxia, and dementia.1 Almost all cases seem to be sporadic; therefore, the elucidation of risk factors is important to clarify the pathological mechanism. Apolipoprotein E4 (ApoE4) is now well established as a risk factor of Alzheimer's disease (AD). Here we report the ApoE allele frequency in PSP, which shares pathological findings such as neurofibrillary tangle (NFT) with AD. NFT is an important sign for the derangement of normal cytoskeletons in degenerating neurons. Although there was no significant increase in ε4 allele frequency in the present series of PSP cases compared with that in the Japanese controls, there was a significant increase in the ε2 allele frequency in PSP compared to controls.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Author information

Authors and Affiliations


Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sawa, A., Amano, N., Yamada, N. et al. Apolipoprotein E in progressive supranuclear palsy in Japan. Mol Psychiatry 2, 341–342 (1997).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI:


  • Apolipoprotein E
  • progressive supranuclear palsy (PSP)
  • Alzheimer


Quick links